Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment

ACS Chemical Biology
Michel WeïwerEdward B Holson

Abstract

Schizophrenia is a severe neuropsychiatric disease that lacks completely effective and safe therapies. As a polygenic disorder, genetic studies have only started to shed light on its complex etiology. To date, the positive symptoms of schizophrenia are well-managed by antipsychotic drugs, which primarily target the dopamine D2 receptor (D2R). However, these antipsychotics are often accompanied by severe side effects, including motoric symptoms. At D2R, antipsychotic drugs antagonize both G-protein dependent (Gαi/o) signaling and G-protein independent (β-arrestin) signaling. However, the relevant contributions of the distinct D2R signaling pathways to antipsychotic efficacy and on-target side effects (motoric) are still incompletely understood. Recent evidence from mouse genetic and pharmacological studies point to β-arrestin signaling as the major driver of antipsychotic efficacy and suggest that a β-arrestin biased D2R antagonist could achieve an additional level of selectivity at D2R, increasing the therapeutic index of next generation antipsychotics. Here, we characterize BRD5814, a highly brain penetrant β-arrestin biased D2R antagonist. BRD5814 demonstrated good target engagement via PET imaging, achieving efficacy in an a...Continue Reading

References

Mar 18, 2003·Bioorganic & Medicinal Chemistry Letters·Taekyu LeeBrian L Largent
Jul 30, 2004·Current Pharmaceutical Design·J AnanthS Gunatilake
Nov 3, 2006·Biochimica Et Biophysica Acta·Lisa A Catapano, Husseini K Manji
Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Bernard MasriMarc G Caron
Mar 28, 2009·Schizophrenia Bulletin·Oliver D Howes, Shitij Kapur
Dec 15, 2010·CNS Neuroscience & Therapeutics·Magdalena Nord, Lars Farde
Dec 18, 2010·Molecular Pharmacology·Nuska TschammerPeter Gmeiner
Dec 25, 2010·Trends in Molecular Medicine·Erin J WhalenRobert J Lefkowitz
Apr 1, 2011·British Journal of Pharmacology·C A JonesK C F Fone
Oct 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·John A AllenJian Jin
Nov 9, 2011·Frontiers in Molecular Neuroscience·Jean-Martin BeaulieuRaul R Gainetdinov
Sep 22, 2012·British Journal of Pharmacology·Terry Kenakin
Dec 14, 2012·Nature·Jérémy BesnardAndrew L Hopkins
Feb 16, 2013·Nature Reviews. Drug Discovery·Terry Kenakin, Arthur Christopoulos
Jun 5, 2013·Journal of Medicinal Chemistry·Christine HillerPeter Gmeiner
May 17, 2014·Journal of Medicinal Chemistry·Dorothee MöllerPeter Gmeiner
Jul 25, 2014·Nature·UNKNOWN Schizophrenia Working Group of the Psychiatric Genomics Consortium
Sep 5, 2015·Nature Medicine
Jan 1, 2015·Nature Reviews. Disease Primers·René S KahnThomas R Insel
Dec 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Nikhil M UrsMarc G Caron
Mar 2, 2017·Journal of Medicinal Chemistry·Dorothee MöllerPeter Gmeiner
Dec 12, 2017·Nature Chemical Biology·John D McCorvyBryan L Roth

❮ Previous
Next ❯

Citations

Aug 22, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Piotr StępnickiAgnieszka A Kaczor
Mar 28, 2019·Pharmacological Reviews·Terry Kenakin
Sep 29, 2019·The Journal of Pharmacology and Experimental Therapeutics·Chloe J JordanCharles W Schindler
Jul 3, 2019·International Journal of Molecular Sciences·Hidetoshi KomatsuYugo Habata
Feb 9, 2021·Frontiers in Neuroscience·Frank S MennitiChristopher J Schmidt
Dec 15, 2020·Pharmacology & Therapeutics·Jaana van GastelStuart Maudsley
Jun 22, 2021·ACS Pharmacology & Translational Science·Jin Hee LeeDo Sup Lee
Jun 22, 2021·ACS Pharmacology & Translational Science·Ziyi LiuResat Cinar
Nov 26, 2021·Bioscience Reports·Gabriela Assis-de-LemosAntonio Galina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Brain Research. Brain Research Reviews
J F Tallman
Proceedings of the National Academy of Sciences of the United States of America
Sean M PetersonMarc G Caron
© 2022 Meta ULC. All rights reserved